Facebook
Twitter
LinkedIn
ForwardPulse: Trippin' Into Treatment: Psychedelics Impact on Modern Psychiatry_enduring
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Within the realm of psychiatric pharmacotherapy, existing treatments often exhibit drawbacks, including delayed onset of action, extensive side effect profiles, and high rates of treatment failure. Emerging literature now indicates the potential efficacy of psychedelics in addressing select psychiatric disorders such as PTSD, treatment-resistant depression, anxiety, and substance use disorders. While uncertainties persist regarding the long-term safety and efficacy of these substances, initial investigations demonstrate promising indications of rapid and sustained clinical improvement.
Target Audience
Pharmacist
Learning Objectives
Define what is a psychedelic substance and discuss their hypothesized mechanisms of action within the body
Review current literature to assess the potential benefits and barriers for implementing treatment with psychedelics
Highlight pending areas of research with psychedelic-assisted psychotherapy
Additional Information
| Attachment | Size |
|---|---|
 Disclosure Slides_Holloway.pdf | 320.97 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Within the realm of psychiatric pharmacotherapy, existing treatments often exhibit drawbacks, including delayed onset of action, extensive side effect profiles, and high rates of treatment failure. Emerging literature now indicates the potential efficacy of psychedelics in addressing select psychiatric disorders such as PTSD, treatment-resistant depression, anxiety, and substance use disorders. While uncertainties persist regarding the long-term safety and efficacy of these substances, initial investigations demonstrate promising indications of rapid and sustained clinical improvement.
Hannah Holloway, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.